nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2C9—brain cancer	0.488	1	CbGaD
Selegiline—CYP2D6—Lomustine—brain cancer	0.0531	0.175	CbGbCtD
Selegiline—CYP1A2—Carmustine—brain cancer	0.0525	0.173	CbGbCtD
Selegiline—CYP2D6—Hydroxyurea—brain cancer	0.0402	0.132	CbGbCtD
Selegiline—CYP3A4—Temozolomide—brain cancer	0.0397	0.131	CbGbCtD
Selegiline—CYP3A4—Lomustine—brain cancer	0.0337	0.111	CbGbCtD
Selegiline—CYP2E1—Etoposide—brain cancer	0.0269	0.0887	CbGbCtD
Selegiline—CYP2C8—Etoposide—brain cancer	0.0201	0.0662	CbGbCtD
Selegiline—CYP1A2—Etoposide—brain cancer	0.0156	0.0513	CbGbCtD
Selegiline—ABCB1—Etoposide—brain cancer	0.0136	0.0448	CbGbCtD
Selegiline—CYP3A4—Etoposide—brain cancer	0.00815	0.0269	CbGbCtD
Selegiline—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.00159	0.0363	CbGpPWpGaD
Selegiline—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00156	0.0356	CbGpPWpGaD
Selegiline—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.0014	0.032	CbGpPWpGaD
Selegiline—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00128	0.0293	CbGpPWpGaD
Selegiline—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00127	0.0291	CbGpPWpGaD
Selegiline—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00126	0.0287	CbGpPWpGaD
Selegiline—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00125	0.0286	CbGpPWpGaD
Selegiline—Pseudoephedrine—IL2—brain cancer	0.00122	0.699	CrCbGaD
Selegiline—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00114	0.026	CbGpPWpGaD
Selegiline—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00109	0.0248	CbGpPWpGaD
Selegiline—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.000985	0.0225	CbGpPWpGaD
Selegiline—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000974	0.0223	CbGpPWpGaD
Selegiline—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.000968	0.0221	CbGpPWpGaD
Selegiline—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000947	0.0216	CbGpPWpGaD
Selegiline—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000891	0.0204	CbGpPWpGaD
Selegiline—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000886	0.0203	CbGpPWpGaD
Selegiline—MAOB—ganglion—brain cancer	0.000862	0.0637	CbGeAlD
Selegiline—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000794	0.0182	CbGpPWpGaD
Selegiline—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.000778	0.0178	CbGpPWpGaD
Selegiline—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000748	0.0171	CbGpPWpGaD
Selegiline—MAOA—ganglion—brain cancer	0.000735	0.0544	CbGeAlD
Selegiline—MAOB—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00068	0.0156	CbGpPWpGaD
Selegiline—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000676	0.0155	CbGpPWpGaD
Selegiline—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000673	0.0154	CbGpPWpGaD
Selegiline—MAOB—hindbrain—brain cancer	0.000654	0.0483	CbGeAlD
Selegiline—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000647	0.0148	CbGpPWpGaD
Selegiline—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.0006	0.0137	CbGpPWpGaD
Selegiline—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.000577	0.0132	CbGpPWpGaD
Selegiline—MAOA—hindbrain—brain cancer	0.000558	0.0412	CbGeAlD
Selegiline—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000552	0.0126	CbGpPWpGaD
Selegiline—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000545	0.0125	CbGpPWpGaD
Selegiline—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000531	0.0121	CbGpPWpGaD
Selegiline—Phentermine—CYP2C9—brain cancer	0.000528	0.301	CrCbGaD
Selegiline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00052	0.0119	CbGpPWpGaD
Selegiline—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000509	0.0116	CbGpPWpGaD
Selegiline—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000468	0.0107	CbGpPWpGaD
Selegiline—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00045	0.0103	CbGpPWpGaD
Selegiline—MAOA—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000427	0.00976	CbGpPWpGaD
Selegiline—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000412	0.00942	CbGpPWpGaD
Selegiline—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000409	0.00935	CbGpPWpGaD
Selegiline—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000403	0.00922	CbGpPWpGaD
Selegiline—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000402	0.0092	CbGpPWpGaD
Selegiline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000383	0.00876	CbGpPWpGaD
Selegiline—MAOB—brainstem—brain cancer	0.000375	0.0277	CbGeAlD
Selegiline—MAOB—Biological oxidations—CYP2C9—brain cancer	0.000361	0.00826	CbGpPWpGaD
Selegiline—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000361	0.00825	CbGpPWpGaD
Selegiline—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000347	0.00794	CbGpPWpGaD
Selegiline—MAOB—telencephalon—brain cancer	0.000332	0.0246	CbGeAlD
Selegiline—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000331	0.00758	CbGpPWpGaD
Selegiline—CYP2D6—hindbrain—brain cancer	0.000331	0.0245	CbGeAlD
Selegiline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00033	0.00754	CbGpPWpGaD
Selegiline—MAOA—Oxidative Stress—SOD2—brain cancer	0.000329	0.00751	CbGpPWpGaD
Selegiline—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000326	0.00744	CbGpPWpGaD
Selegiline—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000323	0.00739	CbGpPWpGaD
Selegiline—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000323	0.00739	CbGpPWpGaD
Selegiline—MAOA—brainstem—brain cancer	0.00032	0.0236	CbGeAlD
Selegiline—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000319	0.00729	CbGpPWpGaD
Selegiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000306	0.00699	CbGpPWpGaD
Selegiline—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000288	0.00659	CbGpPWpGaD
Selegiline—MAOA—telencephalon—brain cancer	0.000284	0.021	CbGeAlD
Selegiline—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000279	0.00638	CbGpPWpGaD
Selegiline—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000276	0.0063	CbGpPWpGaD
Selegiline—MAOB—pituitary gland—brain cancer	0.000271	0.02	CbGeAlD
Selegiline—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000267	0.00611	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—HES5—brain cancer	0.000266	0.00609	CbGpPWpGaD
Selegiline—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000262	0.00599	CbGpPWpGaD
Selegiline—MAOB—medulla oblongata—brain cancer	0.000261	0.0193	CbGeAlD
Selegiline—CYP2A6—cerebellum—brain cancer	0.00025	0.0185	CbGeAlD
Selegiline—ABCB1—blood vessel—brain cancer	0.00025	0.0185	CbGeAlD
Selegiline—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000249	0.0057	CbGpPWpGaD
Selegiline—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000248	0.00567	CbGpPWpGaD
Selegiline—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000246	0.00562	CbGpPWpGaD
Selegiline—MAOB—midbrain—brain cancer	0.000239	0.0177	CbGeAlD
Selegiline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000236	0.0054	CbGpPWpGaD
Selegiline—MAOB—spinal cord—brain cancer	0.000233	0.0172	CbGeAlD
Selegiline—MAOA—pituitary gland—brain cancer	0.000231	0.0171	CbGeAlD
Selegiline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000229	0.00524	CbGpPWpGaD
Selegiline—MAOA—Biological oxidations—CYP2C9—brain cancer	0.000227	0.00518	CbGpPWpGaD
Selegiline—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000226	0.00518	CbGpPWpGaD
Selegiline—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000226	0.00517	CbGpPWpGaD
Selegiline—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000225	0.00514	CbGpPWpGaD
Selegiline—MAOA—medulla oblongata—brain cancer	0.000223	0.0165	CbGeAlD
Selegiline—Pneumonia—Temozolomide—brain cancer	0.000221	0.00148	CcSEcCtD
Selegiline—Anorexia—Procarbazine—brain cancer	0.000221	0.00148	CcSEcCtD
Selegiline—Erythema—Hydroxyurea—brain cancer	0.000219	0.00147	CcSEcCtD
Selegiline—Depression—Temozolomide—brain cancer	0.000219	0.00146	CcSEcCtD
Selegiline—Cardiac arrest—Etoposide—brain cancer	0.000217	0.00145	CcSEcCtD
Selegiline—Nausea—Lomustine—brain cancer	0.000217	0.00145	CcSEcCtD
Selegiline—Hypotension—Procarbazine—brain cancer	0.000216	0.00145	CcSEcCtD
Selegiline—Neuropathy peripheral—Temozolomide—brain cancer	0.000215	0.00144	CcSEcCtD
Selegiline—Stomatitis—Temozolomide—brain cancer	0.000214	0.00143	CcSEcCtD
Selegiline—Urinary tract infection—Temozolomide—brain cancer	0.000213	0.00143	CcSEcCtD
Selegiline—CYP2E1—telencephalon—brain cancer	0.000213	0.0157	CbGeAlD
Selegiline—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000211	0.00141	CcSEcCtD
Selegiline—MAOB—endocrine gland—brain cancer	0.00021	0.0155	CbGeAlD
Selegiline—Insomnia—Procarbazine—brain cancer	0.000209	0.0014	CcSEcCtD
Selegiline—Paraesthesia—Procarbazine—brain cancer	0.000208	0.00139	CcSEcCtD
Selegiline—Hepatobiliary disease—Temozolomide—brain cancer	0.000208	0.00139	CcSEcCtD
Selegiline—MAOB—head—brain cancer	0.000207	0.0153	CbGeAlD
Selegiline—CYP2C8—pituitary gland—brain cancer	0.000206	0.0152	CbGeAlD
Selegiline—Sinusitis—Temozolomide—brain cancer	0.000206	0.00138	CcSEcCtD
Selegiline—Somnolence—Procarbazine—brain cancer	0.000206	0.00138	CcSEcCtD
Selegiline—Cramp muscle—Etoposide—brain cancer	0.000205	0.00137	CcSEcCtD
Selegiline—MAOA—midbrain—brain cancer	0.000204	0.0151	CbGeAlD
Selegiline—Ill-defined disorder—Hydroxyurea—brain cancer	0.000204	0.00136	CcSEcCtD
Selegiline—CYP2A6—brain—brain cancer	0.000203	0.015	CbGeAlD
Selegiline—Anaemia—Hydroxyurea—brain cancer	0.000203	0.00136	CcSEcCtD
Selegiline—Hallucination—Carmustine—brain cancer	0.000203	0.00136	CcSEcCtD
Selegiline—Hypoaesthesia—Carmustine—brain cancer	0.000203	0.00136	CcSEcCtD
Selegiline—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000202	0.00462	CbGpPWpGaD
Selegiline—Decreased appetite—Procarbazine—brain cancer	0.000201	0.00135	CcSEcCtD
Selegiline—Alanine aminotransferase increased—Etoposide—brain cancer	0.000201	0.00134	CcSEcCtD
Selegiline—Oedema peripheral—Carmustine—brain cancer	0.000201	0.00134	CcSEcCtD
Selegiline—Fatigue—Procarbazine—brain cancer	0.0002	0.00133	CcSEcCtD
Selegiline—MAOA—spinal cord—brain cancer	0.000199	0.0147	CbGeAlD
Selegiline—Malaise—Hydroxyurea—brain cancer	0.000198	0.00132	CcSEcCtD
Selegiline—Constipation—Procarbazine—brain cancer	0.000198	0.00132	CcSEcCtD
Selegiline—Pain—Procarbazine—brain cancer	0.000198	0.00132	CcSEcCtD
Selegiline—Hepatitis—Temozolomide—brain cancer	0.000197	0.00132	CcSEcCtD
Selegiline—Dysphagia—Etoposide—brain cancer	0.000197	0.00132	CcSEcCtD
Selegiline—Leukopenia—Hydroxyurea—brain cancer	0.000196	0.00131	CcSEcCtD
Selegiline—Visual impairment—Carmustine—brain cancer	0.000196	0.00131	CcSEcCtD
Selegiline—Hypoaesthesia—Temozolomide—brain cancer	0.000196	0.00131	CcSEcCtD
Selegiline—Hallucination—Temozolomide—brain cancer	0.000196	0.00131	CcSEcCtD
Selegiline—Pharyngitis—Temozolomide—brain cancer	0.000195	0.00131	CcSEcCtD
Selegiline—Urinary tract disorder—Temozolomide—brain cancer	0.000195	0.0013	CcSEcCtD
Selegiline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000194	0.00444	CbGpPWpGaD
Selegiline—Oedema peripheral—Temozolomide—brain cancer	0.000194	0.0013	CcSEcCtD
Selegiline—Urethral disorder—Temozolomide—brain cancer	0.000193	0.00129	CcSEcCtD
Selegiline—Sweating increased—Etoposide—brain cancer	0.000192	0.00128	CcSEcCtD
Selegiline—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000192	0.00438	CbGpPWpGaD
Selegiline—Feeling abnormal—Procarbazine—brain cancer	0.000191	0.00128	CcSEcCtD
Selegiline—Convulsion—Hydroxyurea—brain cancer	0.00019	0.00127	CcSEcCtD
Selegiline—CYP2D6—brainstem—brain cancer	0.00019	0.014	CbGeAlD
Selegiline—Visual impairment—Temozolomide—brain cancer	0.00019	0.00127	CcSEcCtD
Selegiline—CYP2B6—gonad—brain cancer	0.000189	0.014	CbGeAlD
Selegiline—Gastrointestinal pain—Procarbazine—brain cancer	0.000189	0.00127	CcSEcCtD
Selegiline—Flushing—Carmustine—brain cancer	0.000189	0.00127	CcSEcCtD
Selegiline—MAOB—central nervous system—brain cancer	0.000189	0.014	CbGeAlD
Selegiline—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000187	0.00427	CbGpPWpGaD
Selegiline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000186	0.00425	CbGpPWpGaD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000186	0.00124	CcSEcCtD
Selegiline—MAOB—cerebellum—brain cancer	0.000185	0.0137	CbGeAlD
Selegiline—Discomfort—Hydroxyurea—brain cancer	0.000185	0.00123	CcSEcCtD
Selegiline—Urticaria—Procarbazine—brain cancer	0.000184	0.00123	CcSEcCtD
Selegiline—Tinnitus—Temozolomide—brain cancer	0.000184	0.00123	CcSEcCtD
Selegiline—Abdominal pain—Procarbazine—brain cancer	0.000183	0.00122	CcSEcCtD
Selegiline—Body temperature increased—Procarbazine—brain cancer	0.000183	0.00122	CcSEcCtD
Selegiline—Flushing—Temozolomide—brain cancer	0.000183	0.00122	CcSEcCtD
Selegiline—CYP2C19—endocrine gland—brain cancer	0.000183	0.0135	CbGeAlD
Selegiline—Arrhythmia—Carmustine—brain cancer	0.000182	0.00122	CcSEcCtD
Selegiline—Alopecia—Carmustine—brain cancer	0.00018	0.0012	CcSEcCtD
Selegiline—Oedema—Hydroxyurea—brain cancer	0.000179	0.0012	CcSEcCtD
Selegiline—MAOA—endocrine gland—brain cancer	0.000179	0.0132	CbGeAlD
Selegiline—Angiopathy—Temozolomide—brain cancer	0.000179	0.0012	CcSEcCtD
Selegiline—Mental disorder—Carmustine—brain cancer	0.000179	0.00119	CcSEcCtD
Selegiline—Infection—Hydroxyurea—brain cancer	0.000178	0.00119	CcSEcCtD
Selegiline—Malnutrition—Carmustine—brain cancer	0.000177	0.00119	CcSEcCtD
Selegiline—Erythema—Carmustine—brain cancer	0.000177	0.00119	CcSEcCtD
Selegiline—Chills—Temozolomide—brain cancer	0.000177	0.00118	CcSEcCtD
Selegiline—MAOA—head—brain cancer	0.000177	0.0131	CbGeAlD
Selegiline—Pneumonia—Etoposide—brain cancer	0.000177	0.00118	CcSEcCtD
Selegiline—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000176	0.00402	CbGpPWpGaD
Selegiline—Nervous system disorder—Hydroxyurea—brain cancer	0.000176	0.00118	CcSEcCtD
Selegiline—Thrombocytopenia—Hydroxyurea—brain cancer	0.000175	0.00117	CcSEcCtD
Selegiline—Alopecia—Temozolomide—brain cancer	0.000174	0.00116	CcSEcCtD
Selegiline—Skin disorder—Hydroxyurea—brain cancer	0.000174	0.00116	CcSEcCtD
Selegiline—Acute coronary syndrome—Etoposide—brain cancer	0.000173	0.00116	CcSEcCtD
Selegiline—Mental disorder—Temozolomide—brain cancer	0.000173	0.00115	CcSEcCtD
Selegiline—Neuropathy peripheral—Etoposide—brain cancer	0.000172	0.00115	CcSEcCtD
Selegiline—Myocardial infarction—Etoposide—brain cancer	0.000172	0.00115	CcSEcCtD
Selegiline—Back pain—Carmustine—brain cancer	0.000172	0.00115	CcSEcCtD
Selegiline—Erythema—Temozolomide—brain cancer	0.000171	0.00115	CcSEcCtD
Selegiline—Malnutrition—Temozolomide—brain cancer	0.000171	0.00115	CcSEcCtD
Selegiline—Stomatitis—Etoposide—brain cancer	0.000171	0.00114	CcSEcCtD
Selegiline—Anorexia—Hydroxyurea—brain cancer	0.000171	0.00114	CcSEcCtD
Selegiline—Hypersensitivity—Procarbazine—brain cancer	0.000171	0.00114	CcSEcCtD
Selegiline—CYP2D6—telencephalon—brain cancer	0.000169	0.0125	CbGeAlD
Selegiline—Dysgeusia—Temozolomide—brain cancer	0.000168	0.00112	CcSEcCtD
Selegiline—CYP2E1—medulla oblongata—brain cancer	0.000167	0.0124	CbGeAlD
Selegiline—Vision blurred—Carmustine—brain cancer	0.000167	0.00112	CcSEcCtD
Selegiline—Tremor—Carmustine—brain cancer	0.000166	0.00111	CcSEcCtD
Selegiline—Asthenia—Procarbazine—brain cancer	0.000166	0.00111	CcSEcCtD
Selegiline—Hepatobiliary disease—Etoposide—brain cancer	0.000166	0.00111	CcSEcCtD
Selegiline—Back pain—Temozolomide—brain cancer	0.000166	0.00111	CcSEcCtD
Selegiline—Anaemia—Carmustine—brain cancer	0.000164	0.0011	CcSEcCtD
Selegiline—Pruritus—Procarbazine—brain cancer	0.000164	0.0011	CcSEcCtD
Selegiline—Agitation—Carmustine—brain cancer	0.000163	0.00109	CcSEcCtD
Selegiline—Vision blurred—Temozolomide—brain cancer	0.000162	0.00108	CcSEcCtD
Selegiline—MAOA—central nervous system—brain cancer	0.000161	0.0119	CbGeAlD
Selegiline—Tremor—Temozolomide—brain cancer	0.000161	0.00107	CcSEcCtD
Selegiline—Dyspnoea—Hydroxyurea—brain cancer	0.00016	0.00107	CcSEcCtD
Selegiline—CYP2C8—endocrine gland—brain cancer	0.00016	0.0118	CbGeAlD
Selegiline—Somnolence—Hydroxyurea—brain cancer	0.000159	0.00107	CcSEcCtD
Selegiline—Ill-defined disorder—Temozolomide—brain cancer	0.000159	0.00106	CcSEcCtD
Selegiline—Leukopenia—Carmustine—brain cancer	0.000159	0.00106	CcSEcCtD
Selegiline—Anaemia—Temozolomide—brain cancer	0.000158	0.00106	CcSEcCtD
Selegiline—Diarrhoea—Procarbazine—brain cancer	0.000158	0.00106	CcSEcCtD
Selegiline—Dyspepsia—Hydroxyurea—brain cancer	0.000158	0.00105	CcSEcCtD
Selegiline—Agitation—Temozolomide—brain cancer	0.000158	0.00105	CcSEcCtD
Selegiline—MAOA—cerebellum—brain cancer	0.000158	0.0117	CbGeAlD
Selegiline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000157	0.0036	CbGpPWpGaD
Selegiline—Hypoaesthesia—Etoposide—brain cancer	0.000157	0.00105	CcSEcCtD
Selegiline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000157	0.00358	CbGpPWpGaD
Selegiline—Decreased appetite—Hydroxyurea—brain cancer	0.000156	0.00104	CcSEcCtD
Selegiline—Urinary tract disorder—Etoposide—brain cancer	0.000156	0.00104	CcSEcCtD
Selegiline—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000155	0.00103	CcSEcCtD
Selegiline—Malaise—Temozolomide—brain cancer	0.000155	0.00103	CcSEcCtD
Selegiline—Urethral disorder—Etoposide—brain cancer	0.000155	0.00103	CcSEcCtD
Selegiline—Fatigue—Hydroxyurea—brain cancer	0.000154	0.00103	CcSEcCtD
Selegiline—Vertigo—Temozolomide—brain cancer	0.000154	0.00103	CcSEcCtD
Selegiline—Convulsion—Carmustine—brain cancer	0.000154	0.00103	CcSEcCtD
Selegiline—Leukopenia—Temozolomide—brain cancer	0.000153	0.00103	CcSEcCtD
Selegiline—Hypertension—Carmustine—brain cancer	0.000153	0.00102	CcSEcCtD
Selegiline—Pain—Hydroxyurea—brain cancer	0.000153	0.00102	CcSEcCtD
Selegiline—Constipation—Hydroxyurea—brain cancer	0.000153	0.00102	CcSEcCtD
Selegiline—Dizziness—Procarbazine—brain cancer	0.000153	0.00102	CcSEcCtD
Selegiline—Palpitations—Temozolomide—brain cancer	0.000152	0.00101	CcSEcCtD
Selegiline—Myalgia—Carmustine—brain cancer	0.000151	0.00101	CcSEcCtD
Selegiline—Chest pain—Carmustine—brain cancer	0.000151	0.00101	CcSEcCtD
Selegiline—Anxiety—Carmustine—brain cancer	0.000151	0.00101	CcSEcCtD
Selegiline—MAOB—brain—brain cancer	0.00015	0.0111	CbGeAlD
Selegiline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00015	0.00343	CbGpPWpGaD
Selegiline—Cough—Temozolomide—brain cancer	0.00015	0.001	CcSEcCtD
Selegiline—CYP1A2—endocrine gland—brain cancer	0.000149	0.011	CbGeAlD
Selegiline—CYP2E1—spinal cord—brain cancer	0.000149	0.011	CbGeAlD
Selegiline—Convulsion—Temozolomide—brain cancer	0.000149	0.000994	CcSEcCtD
Selegiline—Hypertension—Temozolomide—brain cancer	0.000148	0.00099	CcSEcCtD
Selegiline—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000148	0.00338	CbGpPWpGaD
Selegiline—Feeling abnormal—Hydroxyurea—brain cancer	0.000148	0.000987	CcSEcCtD
Selegiline—Vomiting—Procarbazine—brain cancer	0.000147	0.000984	CcSEcCtD
Selegiline—Flushing—Etoposide—brain cancer	0.000146	0.000978	CcSEcCtD
Selegiline—Confusional state—Carmustine—brain cancer	0.000146	0.000977	CcSEcCtD
Selegiline—Myalgia—Temozolomide—brain cancer	0.000146	0.000976	CcSEcCtD
Selegiline—Arthralgia—Temozolomide—brain cancer	0.000146	0.000976	CcSEcCtD
Selegiline—Rash—Procarbazine—brain cancer	0.000146	0.000976	CcSEcCtD
Selegiline—Dermatitis—Procarbazine—brain cancer	0.000146	0.000975	CcSEcCtD
Selegiline—Anxiety—Temozolomide—brain cancer	0.000145	0.000973	CcSEcCtD
Selegiline—Headache—Procarbazine—brain cancer	0.000145	0.00097	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000145	0.00097	CcSEcCtD
Selegiline—Oedema—Carmustine—brain cancer	0.000145	0.000969	CcSEcCtD
Selegiline—Discomfort—Temozolomide—brain cancer	0.000144	0.000965	CcSEcCtD
Selegiline—Infection—Carmustine—brain cancer	0.000144	0.000962	CcSEcCtD
Selegiline—CYP2B6—endocrine gland—brain cancer	0.000143	0.0106	CbGeAlD
Selegiline—Angiopathy—Etoposide—brain cancer	0.000143	0.000957	CcSEcCtD
Selegiline—Dry mouth—Temozolomide—brain cancer	0.000143	0.000955	CcSEcCtD
Selegiline—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000142	0.00325	CbGpPWpGaD
Selegiline—Thrombocytopenia—Carmustine—brain cancer	0.000142	0.000948	CcSEcCtD
Selegiline—CYP2C9—endocrine gland—brain cancer	0.000142	0.0105	CbGeAlD
Selegiline—Body temperature increased—Hydroxyurea—brain cancer	0.000142	0.000947	CcSEcCtD
Selegiline—Chills—Etoposide—brain cancer	0.000141	0.000946	CcSEcCtD
Selegiline—Tachycardia—Carmustine—brain cancer	0.000141	0.000945	CcSEcCtD
Selegiline—CYP2B6—head—brain cancer	0.000141	0.0104	CbGeAlD
Selegiline—Confusional state—Temozolomide—brain cancer	0.000141	0.000944	CcSEcCtD
Selegiline—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.00014	0.0032	CbGpPWpGaD
Selegiline—Oedema—Temozolomide—brain cancer	0.00014	0.000936	CcSEcCtD
Selegiline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	0.00014	0.00319	CbGpPWpGaD
Selegiline—Alopecia—Etoposide—brain cancer	0.000139	0.000932	CcSEcCtD
Selegiline—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000139	0.00318	CbGpPWpGaD
Selegiline—Infection—Temozolomide—brain cancer	0.000139	0.00093	CcSEcCtD
Selegiline—Anorexia—Carmustine—brain cancer	0.000138	0.000923	CcSEcCtD
Selegiline—Nausea—Procarbazine—brain cancer	0.000137	0.00092	CcSEcCtD
Selegiline—Nervous system disorder—Temozolomide—brain cancer	0.000137	0.000918	CcSEcCtD
Selegiline—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000137	0.00314	CbGpPWpGaD
Selegiline—Thrombocytopenia—Temozolomide—brain cancer	0.000137	0.000917	CcSEcCtD
Selegiline—Skin disorder—Temozolomide—brain cancer	0.000136	0.000909	CcSEcCtD
Selegiline—Hypotension—Carmustine—brain cancer	0.000135	0.000905	CcSEcCtD
Selegiline—Hyperhidrosis—Temozolomide—brain cancer	0.000135	0.000905	CcSEcCtD
Selegiline—Dysgeusia—Etoposide—brain cancer	0.000134	0.000899	CcSEcCtD
Selegiline—CYP2E1—endocrine gland—brain cancer	0.000134	0.00993	CbGeAlD
Selegiline—Anorexia—Temozolomide—brain cancer	0.000133	0.000892	CcSEcCtD
Selegiline—Back pain—Etoposide—brain cancer	0.000133	0.000888	CcSEcCtD
Selegiline—CYP2E1—head—brain cancer	0.000133	0.00981	CbGeAlD
Selegiline—Hypersensitivity—Hydroxyurea—brain cancer	0.000132	0.000883	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Carmustine—brain cancer	0.000132	0.000883	CcSEcCtD
Selegiline—Muscle spasms—Etoposide—brain cancer	0.000132	0.000882	CcSEcCtD
Selegiline—Insomnia—Carmustine—brain cancer	0.000131	0.000876	CcSEcCtD
Selegiline—Paraesthesia—Carmustine—brain cancer	0.00013	0.00087	CcSEcCtD
Selegiline—Dyspnoea—Carmustine—brain cancer	0.000129	0.000864	CcSEcCtD
Selegiline—CYP2B6—central nervous system—brain cancer	0.000129	0.00954	CbGeAlD
Selegiline—Somnolence—Carmustine—brain cancer	0.000129	0.000861	CcSEcCtD
Selegiline—Asthenia—Hydroxyurea—brain cancer	0.000129	0.00086	CcSEcCtD
Selegiline—MAOA—brain—brain cancer	0.000128	0.00947	CbGeAlD
Selegiline—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000127	0.000853	CcSEcCtD
Selegiline—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000127	0.00291	CbGpPWpGaD
Selegiline—Ill-defined disorder—Etoposide—brain cancer	0.000127	0.000852	CcSEcCtD
Selegiline—Anaemia—Etoposide—brain cancer	0.000127	0.000848	CcSEcCtD
Selegiline—Insomnia—Temozolomide—brain cancer	0.000127	0.000847	CcSEcCtD
Selegiline—Decreased appetite—Carmustine—brain cancer	0.000126	0.000842	CcSEcCtD
Selegiline—Paraesthesia—Temozolomide—brain cancer	0.000126	0.000841	CcSEcCtD
Selegiline—Gastrointestinal disorder—Carmustine—brain cancer	0.000125	0.000836	CcSEcCtD
Selegiline—Dyspnoea—Temozolomide—brain cancer	0.000125	0.000835	CcSEcCtD
Selegiline—Somnolence—Temozolomide—brain cancer	0.000124	0.000832	CcSEcCtD
Selegiline—Constipation—Carmustine—brain cancer	0.000124	0.000828	CcSEcCtD
Selegiline—Pain—Carmustine—brain cancer	0.000124	0.000828	CcSEcCtD
Selegiline—Malaise—Etoposide—brain cancer	0.000124	0.000828	CcSEcCtD
Selegiline—Vertigo—Etoposide—brain cancer	0.000123	0.000825	CcSEcCtD
Selegiline—Dyspepsia—Temozolomide—brain cancer	0.000123	0.000824	CcSEcCtD
Selegiline—Leukopenia—Etoposide—brain cancer	0.000123	0.000822	CcSEcCtD
Selegiline—Diarrhoea—Hydroxyurea—brain cancer	0.000123	0.00082	CcSEcCtD
Selegiline—Decreased appetite—Temozolomide—brain cancer	0.000122	0.000814	CcSEcCtD
Selegiline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000122	0.00278	CbGpPWpGaD
Selegiline—ABCB1—telencephalon—brain cancer	0.000121	0.00897	CbGeAlD
Selegiline—CYP2E1—central nervous system—brain cancer	0.000121	0.00895	CbGeAlD
Selegiline—Gastrointestinal disorder—Temozolomide—brain cancer	0.000121	0.000808	CcSEcCtD
Selegiline—Fatigue—Temozolomide—brain cancer	0.000121	0.000807	CcSEcCtD
Selegiline—Loss of consciousness—Etoposide—brain cancer	0.000121	0.000807	CcSEcCtD
Selegiline—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.00012	0.00275	CbGpPWpGaD
Selegiline—Cough—Etoposide—brain cancer	0.00012	0.000801	CcSEcCtD
Selegiline—Constipation—Temozolomide—brain cancer	0.00012	0.0008	CcSEcCtD
Selegiline—Pain—Temozolomide—brain cancer	0.00012	0.0008	CcSEcCtD
Selegiline—Feeling abnormal—Carmustine—brain cancer	0.000119	0.000798	CcSEcCtD
Selegiline—Convulsion—Etoposide—brain cancer	0.000119	0.000795	CcSEcCtD
Selegiline—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000119	0.00271	CbGpPWpGaD
Selegiline—Hypertension—Etoposide—brain cancer	0.000118	0.000792	CcSEcCtD
Selegiline—Dizziness—Hydroxyurea—brain cancer	0.000118	0.000792	CcSEcCtD
Selegiline—Gastrointestinal pain—Carmustine—brain cancer	0.000118	0.000792	CcSEcCtD
Selegiline—CYP2E1—cerebellum—brain cancer	0.000118	0.00875	CbGeAlD
Selegiline—Chest pain—Etoposide—brain cancer	0.000117	0.000781	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000116	0.000776	CcSEcCtD
Selegiline—Discomfort—Etoposide—brain cancer	0.000115	0.000772	CcSEcCtD
Selegiline—Feeling abnormal—Temozolomide—brain cancer	0.000115	0.000771	CcSEcCtD
Selegiline—Body temperature increased—Carmustine—brain cancer	0.000114	0.000766	CcSEcCtD
Selegiline—Abdominal pain—Carmustine—brain cancer	0.000114	0.000766	CcSEcCtD
Selegiline—Gastrointestinal pain—Temozolomide—brain cancer	0.000114	0.000765	CcSEcCtD
Selegiline—CYP2C8—brain—brain cancer	0.000114	0.00844	CbGeAlD
Selegiline—Vomiting—Hydroxyurea—brain cancer	0.000114	0.000762	CcSEcCtD
Selegiline—MAOA—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000113	0.00259	CbGpPWpGaD
Selegiline—Rash—Hydroxyurea—brain cancer	0.000113	0.000756	CcSEcCtD
Selegiline—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000113	0.00258	CbGpPWpGaD
Selegiline—Confusional state—Etoposide—brain cancer	0.000113	0.000755	CcSEcCtD
Selegiline—Dermatitis—Hydroxyurea—brain cancer	0.000113	0.000755	CcSEcCtD
Selegiline—Headache—Hydroxyurea—brain cancer	0.000112	0.000751	CcSEcCtD
Selegiline—Infection—Etoposide—brain cancer	0.000111	0.000744	CcSEcCtD
Selegiline—Urticaria—Temozolomide—brain cancer	0.000111	0.000744	CcSEcCtD
Selegiline—Abdominal pain—Temozolomide—brain cancer	0.000111	0.00074	CcSEcCtD
Selegiline—Body temperature increased—Temozolomide—brain cancer	0.000111	0.00074	CcSEcCtD
Selegiline—Thrombocytopenia—Etoposide—brain cancer	0.00011	0.000733	CcSEcCtD
Selegiline—Tachycardia—Etoposide—brain cancer	0.000109	0.000731	CcSEcCtD
Selegiline—Skin disorder—Etoposide—brain cancer	0.000109	0.000728	CcSEcCtD
Selegiline—Hyperhidrosis—Etoposide—brain cancer	0.000108	0.000724	CcSEcCtD
Selegiline—CYP3A4—endocrine gland—brain cancer	0.000108	0.00799	CbGeAlD
Selegiline—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000107	0.00245	CbGpPWpGaD
Selegiline—Anorexia—Etoposide—brain cancer	0.000107	0.000714	CcSEcCtD
Selegiline—Hypersensitivity—Carmustine—brain cancer	0.000107	0.000714	CcSEcCtD
Selegiline—Nausea—Hydroxyurea—brain cancer	0.000106	0.000712	CcSEcCtD
Selegiline—CYP2D6—endocrine gland—brain cancer	0.000106	0.00786	CbGeAlD
Selegiline—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000106	0.00242	CbGpPWpGaD
Selegiline—CYP2D6—head—brain cancer	0.000105	0.00776	CbGeAlD
Selegiline—Hypotension—Etoposide—brain cancer	0.000105	0.0007	CcSEcCtD
Selegiline—Asthenia—Carmustine—brain cancer	0.000104	0.000695	CcSEcCtD
Selegiline—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000104	0.00237	CbGpPWpGaD
Selegiline—Hypersensitivity—Temozolomide—brain cancer	0.000103	0.00069	CcSEcCtD
Selegiline—CYP2B6—brain—brain cancer	0.000102	0.00757	CbGeAlD
Selegiline—ABCB1—gonad—brain cancer	0.000101	0.00749	CbGeAlD
Selegiline—Paraesthesia—Etoposide—brain cancer	0.000101	0.000673	CcSEcCtD
Selegiline—Asthenia—Temozolomide—brain cancer	0.0001	0.000672	CcSEcCtD
Selegiline—Dyspnoea—Etoposide—brain cancer	9.98e-05	0.000668	CcSEcCtD
Selegiline—Somnolence—Etoposide—brain cancer	9.95e-05	0.000666	CcSEcCtD
Selegiline—Diarrhoea—Carmustine—brain cancer	9.91e-05	0.000663	CcSEcCtD
Selegiline—Pruritus—Temozolomide—brain cancer	9.9e-05	0.000662	CcSEcCtD
Selegiline—CYP2D6—Biological oxidations—CYP2C9—brain cancer	9.87e-05	0.00226	CbGpPWpGaD
Selegiline—ABCB1—pituitary gland—brain cancer	9.87e-05	0.0073	CbGeAlD
Selegiline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	9.78e-05	0.00224	CbGpPWpGaD
Selegiline—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	9.74e-05	0.00223	CbGpPWpGaD
Selegiline—CYP3A4—central nervous system—brain cancer	9.74e-05	0.0072	CbGeAlD
Selegiline—Decreased appetite—Etoposide—brain cancer	9.73e-05	0.000651	CcSEcCtD
Selegiline—Gastrointestinal disorder—Etoposide—brain cancer	9.67e-05	0.000647	CcSEcCtD
Selegiline—Fatigue—Etoposide—brain cancer	9.65e-05	0.000646	CcSEcCtD
Selegiline—CYP2E1—brain—brain cancer	9.61e-05	0.00711	CbGeAlD
Selegiline—CYP2D6—central nervous system—brain cancer	9.58e-05	0.00709	CbGeAlD
Selegiline—Dizziness—Carmustine—brain cancer	9.58e-05	0.000641	CcSEcCtD
Selegiline—Constipation—Etoposide—brain cancer	9.58e-05	0.000641	CcSEcCtD
Selegiline—Pain—Etoposide—brain cancer	9.58e-05	0.000641	CcSEcCtD
Selegiline—Diarrhoea—Temozolomide—brain cancer	9.57e-05	0.00064	CcSEcCtD
Selegiline—ABCB1—medulla oblongata—brain cancer	9.53e-05	0.00705	CbGeAlD
Selegiline—CYP2D6—cerebellum—brain cancer	9.36e-05	0.00693	CbGeAlD
Selegiline—Dizziness—Temozolomide—brain cancer	9.25e-05	0.000619	CcSEcCtD
Selegiline—Feeling abnormal—Etoposide—brain cancer	9.23e-05	0.000617	CcSEcCtD
Selegiline—Vomiting—Carmustine—brain cancer	9.21e-05	0.000616	CcSEcCtD
Selegiline—Gastrointestinal pain—Etoposide—brain cancer	9.16e-05	0.000613	CcSEcCtD
Selegiline—Rash—Carmustine—brain cancer	9.13e-05	0.000611	CcSEcCtD
Selegiline—Dermatitis—Carmustine—brain cancer	9.12e-05	0.00061	CcSEcCtD
Selegiline—Headache—Carmustine—brain cancer	9.07e-05	0.000607	CcSEcCtD
Selegiline—Vomiting—Temozolomide—brain cancer	8.9e-05	0.000595	CcSEcCtD
Selegiline—Urticaria—Etoposide—brain cancer	8.9e-05	0.000595	CcSEcCtD
Selegiline—Abdominal pain—Etoposide—brain cancer	8.85e-05	0.000592	CcSEcCtD
Selegiline—Body temperature increased—Etoposide—brain cancer	8.85e-05	0.000592	CcSEcCtD
Selegiline—Rash—Temozolomide—brain cancer	8.82e-05	0.00059	CcSEcCtD
Selegiline—Dermatitis—Temozolomide—brain cancer	8.82e-05	0.00059	CcSEcCtD
Selegiline—MAOA—SIDS Susceptibility Pathways—HES1—brain cancer	8.81e-05	0.00201	CbGpPWpGaD
Selegiline—Headache—Temozolomide—brain cancer	8.77e-05	0.000586	CcSEcCtD
Selegiline—ABCB1—midbrain—brain cancer	8.71e-05	0.00644	CbGeAlD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	8.63e-05	0.00197	CbGpPWpGaD
Selegiline—Nausea—Carmustine—brain cancer	8.6e-05	0.000575	CcSEcCtD
Selegiline—ABCB1—spinal cord—brain cancer	8.5e-05	0.00628	CbGeAlD
Selegiline—CYP1A2—Biological oxidations—CYP2C9—brain cancer	8.36e-05	0.00191	CbGpPWpGaD
Selegiline—Nausea—Temozolomide—brain cancer	8.31e-05	0.000556	CcSEcCtD
Selegiline—Hypersensitivity—Etoposide—brain cancer	8.25e-05	0.000552	CcSEcCtD
Selegiline—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	8.25e-05	0.00189	CbGpPWpGaD
Selegiline—Asthenia—Etoposide—brain cancer	8.03e-05	0.000537	CcSEcCtD
Selegiline—Pruritus—Etoposide—brain cancer	7.92e-05	0.00053	CcSEcCtD
Selegiline—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	7.9e-05	0.00181	CbGpPWpGaD
Selegiline—Diarrhoea—Etoposide—brain cancer	7.66e-05	0.000513	CcSEcCtD
Selegiline—ABCB1—endocrine gland—brain cancer	7.65e-05	0.00566	CbGeAlD
Selegiline—CYP2D6—brain—brain cancer	7.61e-05	0.00563	CbGeAlD
Selegiline—ABCB1—head—brain cancer	7.55e-05	0.00558	CbGeAlD
Selegiline—Dizziness—Etoposide—brain cancer	7.4e-05	0.000495	CcSEcCtD
Selegiline—Vomiting—Etoposide—brain cancer	7.12e-05	0.000476	CcSEcCtD
Selegiline—Rash—Etoposide—brain cancer	7.06e-05	0.000472	CcSEcCtD
Selegiline—Dermatitis—Etoposide—brain cancer	7.05e-05	0.000472	CcSEcCtD
Selegiline—Headache—Etoposide—brain cancer	7.02e-05	0.000469	CcSEcCtD
Selegiline—ABCB1—central nervous system—brain cancer	6.89e-05	0.0051	CbGeAlD
Selegiline—ABCB1—cerebellum—brain cancer	6.74e-05	0.00498	CbGeAlD
Selegiline—ABCB1—Allograft Rejection—PDGFRA—brain cancer	6.68e-05	0.00153	CbGpPWpGaD
Selegiline—Nausea—Etoposide—brain cancer	6.65e-05	0.000445	CcSEcCtD
Selegiline—CYP3A4—Biological oxidations—CYP2C9—brain cancer	6.46e-05	0.00148	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	6.37e-05	0.00146	CbGpPWpGaD
Selegiline—MAOB—Metabolism—CYP2C9—brain cancer	6.18e-05	0.00141	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	5.57e-05	0.00127	CbGpPWpGaD
Selegiline—ABCB1—brain—brain cancer	5.47e-05	0.00405	CbGeAlD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	5.28e-05	0.00121	CbGpPWpGaD
Selegiline—MAOB—Metabolism—BSG—brain cancer	5.26e-05	0.0012	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.98e-05	0.00114	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.62e-05	0.00106	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	4.62e-05	0.00106	CbGpPWpGaD
Selegiline—MAOB—Metabolism—IDH1—brain cancer	4.52e-05	0.00103	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.48e-05	0.00102	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	4.46e-05	0.00102	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—CTNNB1—brain cancer	4.42e-05	0.00101	CbGpPWpGaD
Selegiline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	4.17e-05	0.000954	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.12e-05	0.000942	CbGpPWpGaD
Selegiline—MAOA—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.89e-05	0.000889	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CYP2C9—brain cancer	3.88e-05	0.000887	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.81e-05	0.000871	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	3.66e-05	0.000836	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—IL2—brain cancer	3.64e-05	0.000833	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	3.59e-05	0.00082	CbGpPWpGaD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	3.57e-05	0.000817	CbGpPWpGaD
Selegiline—MAOB—Metabolism—ENO2—brain cancer	3.57e-05	0.000817	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	3.54e-05	0.00081	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.5e-05	0.000801	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.43e-05	0.000784	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.43e-05	0.000784	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.38e-05	0.000772	CbGpPWpGaD
Selegiline—MAOA—Metabolism—BSG—brain cancer	3.3e-05	0.000754	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	3.29e-05	0.000753	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.21e-05	0.000734	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	3.14e-05	0.000718	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—VEGFA—brain cancer	3.1e-05	0.000708	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.01e-05	0.000689	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP2C9—brain cancer	3.01e-05	0.000688	CbGpPWpGaD
Selegiline—MAOA—Metabolism—IDH1—brain cancer	2.84e-05	0.000648	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.75e-05	0.000628	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.71e-05	0.00062	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—BSG—brain cancer	2.56e-05	0.000585	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	2.55e-05	0.000584	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP2C9—brain cancer	2.43e-05	0.000555	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP2C9—brain cancer	2.38e-05	0.000544	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.35e-05	0.000537	CbGpPWpGaD
Selegiline—MAOA—Metabolism—ENO2—brain cancer	2.24e-05	0.000512	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—IDH1—brain cancer	2.2e-05	0.000503	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	2.13e-05	0.000487	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—BSG—brain cancer	2.07e-05	0.000472	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP2C9—brain cancer	2.06e-05	0.00047	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—BSG—brain cancer	2.02e-05	0.000462	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.98e-05	0.000453	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP2C9—brain cancer	1.84e-05	0.00042	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP2C9—brain cancer	1.79e-05	0.00041	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—IDH1—brain cancer	1.78e-05	0.000406	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.75e-05	0.000401	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—BSG—brain cancer	1.75e-05	0.0004	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—ENO2—brain cancer	1.74e-05	0.000398	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—IDH1—brain cancer	1.74e-05	0.000398	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.74e-05	0.000397	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP2C9—brain cancer	1.69e-05	0.000386	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CG—brain cancer	1.64e-05	0.000375	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—BSG—brain cancer	1.56e-05	0.000357	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.53e-05	0.000349	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—BSG—brain cancer	1.52e-05	0.000348	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—IDH1—brain cancer	1.5e-05	0.000344	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—BSG—brain cancer	1.44e-05	0.000328	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP2C9—brain cancer	1.43e-05	0.000327	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—BSG—brain cancer	1.42e-05	0.000325	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.41e-05	0.000321	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—ENO2—brain cancer	1.4e-05	0.000321	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—ENO2—brain cancer	1.38e-05	0.000314	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.37e-05	0.000314	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—IDH1—brain cancer	1.34e-05	0.000307	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—IDH1—brain cancer	1.31e-05	0.000299	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—IDH1—brain cancer	1.23e-05	0.000282	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.22e-05	0.00028	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—IDH1—brain cancer	1.22e-05	0.00028	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—BSG—brain cancer	1.22e-05	0.000278	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—ENO2—brain cancer	1.19e-05	0.000272	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.15e-05	0.000264	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP2C9—brain cancer	1.1e-05	0.000252	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.09e-05	0.00025	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—ENO2—brain cancer	1.06e-05	0.000243	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—IDH1—brain cancer	1.05e-05	0.000239	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—ENO2—brain cancer	1.04e-05	0.000237	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CG—brain cancer	1.03e-05	0.000235	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.97e-06	0.000228	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—ENO2—brain cancer	9.76e-06	0.000223	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—ENO2—brain cancer	9.67e-06	0.000221	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—BSG—brain cancer	9.39e-06	0.000215	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.52e-06	0.000195	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—ENO2—brain cancer	8.27e-06	0.000189	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—IDH1—brain cancer	8.07e-06	0.000185	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CG—brain cancer	7.98e-06	0.000182	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CG—brain cancer	6.44e-06	0.000147	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—ENO2—brain cancer	6.38e-06	0.000146	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CG—brain cancer	6.31e-06	0.000144	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CG—brain cancer	5.45e-06	0.000125	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CG—brain cancer	4.87e-06	0.000111	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CG—brain cancer	4.75e-06	0.000109	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CG—brain cancer	4.48e-06	0.000102	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CG—brain cancer	4.44e-06	0.000101	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CG—brain cancer	3.79e-06	8.67e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CG—brain cancer	2.93e-06	6.69e-05	CbGpPWpGaD
